Gene: SMIM6
Official Full Name: endoregulinprovided by HGNC
Gene Summary: Predicted to act upstream of or within negative regulation of ATPase-coupled calcium transmembrane transporter activity. Predicted to be located in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13933 | SMIM6 Knockout cell line (A549) | Human | SMIM6 | 1:3~1:4 | Negative | Online Inquiry |
SMIM6 Gene Knockout Cell Lines are genetically modified cell lines that have had the SMIM6 gene selectively inactivated, providing a powerful tool for investigating the role of this gene in various biological processes. The SMIM6 gene is implicated in several physiological functions, including red blood cell development and membrane dynamics. By employing CRISPR/Cas9 or similar gene-editing technologies, these cell lines facilitate comprehensive studies on gene function, allowing researchers to observe phenotypic alterations and measure cellular responses in the absence of the SMIM6 protein.
The key mechanism behind these knockout cell lines involves the precise deletion or disruption of the SMIM6 gene, leading to altered gene expression pathways and subsequent downstream effects. Researchers can utilize these cell lines to elucidate the gene's role in pathophysiological conditions, including hematological disorders and membrane stability issues. The ability to analyze cellular behaviors in a controlled genetic background enhances the reproducibility and reliability of experimental data.
In terms of scientific importance, SMIM6 Gene Knockout Cell Lines are invaluable in both research and clinical settings. They offer a unique model for drug discovery and the evaluation of therapeutic interventions, allowing scientists to assess the impact of potential treatments on cells lacking SMIM6. This specific knowledge can pave the way for advancements in therapies aimed at diseases linked to SMIM6 dysfunction.
One of the primary advantages of utilizing SMIM6 Gene Knockout Cell Lines is their specificity and clarity. Unlike broad-spectrum inhibitors or other nonspecific tools, these knockout cell lines allow researchers to pinpoint the precise effects of SMIM6 in various cellular contexts without interference from the gene's activity. This specificity enhances experimental outcomes and accelerates the path toward elucidating complex biological questions.
Researchers, clinicians, and pharmaceutical professionals will find great value in these cell lines, as they represent a cutting-edge resource for both fundamental and applied studies. The insights gained through their use can lead to significant advancements in understanding disease mechanisms and identifying novel therapeutic targets.
Our company is committed to providing high-quality biological research products backed by rigorous scientific advancements. With expertise in genetic engineering and cellular models, we offer a portfolio designed to support groundbreaking research and accelerate scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.